Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Institute of Hematology and Blood Transfusion, Czech Republic
Thomas Jefferson University
Children's Hospital of Philadelphia
Beth Israel Deaconess Medical Center
The First Affiliated Hospital of Soochow University
Roswell Park Cancer Institute
The First Affiliated Hospital with Nanjing Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Nationwide Children's Hospital
Taiho Oncology, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Changhai Hospital
Regeneron Pharmaceuticals
Murdoch Childrens Research Institute
University Hospital, Brest
Dana-Farber Cancer Institute
Cedars-Sinai Medical Center
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Shanghai Pulmonary Hospital, Shanghai, China
Masonic Cancer Center, University of Minnesota
Takeda
Fred Hutchinson Cancer Center
Disc Medicine, Inc
Massachusetts General Hospital
M.D. Anderson Cancer Center
Chongqing Peg-Bio Biopharm Co., Ltd.
Zhejiang Cancer Hospital
Roswell Park Cancer Institute
Kind Pharmaceuticals LLC
Kind Pharmaceuticals LLC
Ossium Health, Inc.
Mayo Clinic
Anthos Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Stanford University
M.D. Anderson Cancer Center